On November 13, WUXI APPTEC fell 3.03% in Regular Trading to HK$195.3, with turnover of HK$193 million.
The move came as the market reassessed the durability of the recent relief rally after the company was removed from the US Department of Defense 1260H list, while renewed focus shifted to remaining cross-border regulatory uncertainties.
Recent developments had initially supported sentiment: the Pentagon removed WUXI APPTEC from the 1260H list following compliance with a court order tied to a preliminary injunction, and several brokers maintained positive ratings, including target prices of HK$233, HK$240 and HK$251. However, published market commentary also noted that the delisting was procedural rather than a full resolution of geopolitical risk, with attention now turning to potential BIOSECURE-related developments and the possible BCC list. Sector pressure was also visible, with peers including WUXI BIO, WUXI XDC, INSILICO and XTALPI all trading lower.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments